Quest Diagnostics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.About DGX
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments.
DGX Key Statistics
Stock Snapshot
With a market cap of 21.72B, Quest Diagnostics(DGX) trades at $196.27. The stock has a price-to-earnings ratio of 21.65 and currently yields dividends of 1.6%.
On 2026-04-26, Quest Diagnostics(DGX) stock moved within a range of $194.46 to $200.07. With shares now at $196.27, the stock is trading +0.9% above its intraday low and -1.9% below the session's peak.
Trading volume for Quest Diagnostics(DGX) stock has reached 1.02M, versus its average volume of 1.3M.
Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $213.50 and a low of $164.65.
Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $213.50 and a low of $164.65.
DGX News
If you are wondering whether Quest Diagnostics at around US$204 is offering solid value or asking too much, you are in the right place for a closer look at what...
Quest Diagnostics (DGX) was added as a new short idea at Hedgeye with downside potential of 20%. Hedgeye was previously long, though it's now changing to short...
Truist raised the firm’s price target on Quest Diagnostics (DGX) to $225 from $220 and keeps a Hold rating on the shares after its Q1 earnings beat. Core trends...
Analyst ratings
55%
of 22 ratingsMore DGX News
Quest Diagnostics ((DGX)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Unlock hedge fund-level data and po...
Image source: The Motley Fool. Tuesday, April 21, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman, Chief Executive Officer, and President — James E. Davis Exec...
Quest Diagnostics Reports Strong Organic Growth The provider of diagnostic information services reported sales of $2.895 billion, up 9.2% year over year, beati...
Shares of Quest Diagnostics (DGX) rose on Tuesday after the New Jersey-based provider of diagnostic testing and services reported better-than-expected financial...
(RTTNews) - Quest Diagnostics (DGX) said, for full year 2026, the company now expects adjusted diluted EPS in a range of $10.63 $10.83, revised from prior guida...
On 16 April 2026, Quest Diagnostics announced that City of Hope is using its Haystack MRD circulating-tumor DNA test in multi-year clinical trials for about 500...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.